NASH
Non-Alcoholic Steatohepatitis, a liver disease involving fat accumulation and inflammation, potentially improved by GLP-1 drugs.
As defined in How to Be a Super Ager (with Eric Topol)
Where it comes up · 2
- How to Be a Super Ager (with Eric Topol)1 claim
- Dr. Peter Attia - The Portfolio to Live Longer - [Invest Like the Best, EP.325]1 claim
Most important claims · 2 of 2Search all claims for “NASH” →
- GLP-1 drugs reduce inflammation in the brain and body before any measurable weight loss occurs, meaning their anti-inflammatory benefit is a direct drug effect and not merely a consequence of losing inflammatory adipose tissue—raising the possibility they could prevent Alzheimer's, with trials due in early 2026.How to Be a Super Ager (with Eric Topol)
- Attia's four horsemen of slow death are cardiovascular and cerebrovascular disease, cancer, and neurodegenerative disease, with a fourth category of metabolic dysfunction (insulin resistance, hyperinsulinemia, NAFLD progressing to NASH, and type 2 diabetes) that never appears on death certificates but amplifies the other three.Dr. Peter Attia - The Portfolio to Live Longer - [Invest Like the Best, EP.325]